Client News

RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients

MagForce AG and CHIP Hospital Málaga Announce Collaboration Agreement for the Commercial Treatment of Glioblastoma Cancer Patients with the NanoTherm Therapy System in Spain

Abivax presents first-half 2021 financial results and operations update

Marinomed’s Investor Relations to be Strengthened by Stephanie Kniep

Deutsches Herzzentrum München leitet klinische Studie von Volta Medical zur Evaluierung der auf Künstlicher Intelligenz basierenden VX1-Technologie zur Behandlung von persistierenden Herzrhythmusstörungen

Volta Medical führt neuartige, auf Künstlicher Intelligenz basierende Technologie VX1 zur Behandlung von persistierenden Herzrhythmusstörungen an ausgewählten klinischen Zentren in Deutschland ein

AiCuris starts pilot trial with proprietary immunomodulator AIC649, a unique therapy to prevent severe symptoms in SARS-CoV-2 infections

Newron announces Half-Year 2021 results

Temedica develops new digital companion Brisa for people with multiple sclerosis in cooperation with Roche

Abivax provides an update on the ABX464 clinical data and development strategy in ulcerative colitis